Aldebaran Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $567K | Buy |
3,055
+10
| +0.3% | +$1.86K | 0.63% | 41 |
|
|
2025
Q1 | $638K | Buy |
3,045
+381
| +14% | +$79.8K | 0.78% | 35 |
|
|
2024
Q4 | $469K | Buy |
2,664
+304
| +13% | +$53.6K | 0.55% | 48 |
|
|
2024
Q3 | $466K | Buy |
+2,360
| New | +$466K | 0.55% | 44 |
|
|
2024
Q2 | – | Sell |
-1,100
| Closed | -$200K | – | 65 |
|
|
2024
Q1 | $200K | Buy |
+1,100
| New | +$200K | 0.28% | 62 |
|
|
2023
Q1 | – | Sell |
-2,950
| Closed | -$477K | – | 73 |
|
|
2022
Q4 | $477K | Hold |
2,950
| – | – | 0.51% | 51 |
|
|
2022
Q3 | $401K | Hold |
2,950
| – | – | 0.44% | 56 |
|
|
2022
Q2 | $450K | Sell |
2,950
-6,925
| -70% | -$1.06M | 0.48% | 52 |
|
|
2022
Q1 | $1.6M | Sell |
9,875
-125
| -1% | -$20.3K | 1.24% | 23 |
|
|
2021
Q4 | $1.35M | Buy |
10,000
+51
| +0.5% | +$6.91K | 1% | 29 |
|
|
2021
Q3 | $1.07M | Buy |
9,949
+217
| +2% | +$23.4K | 0.87% | 35 |
|
|
2021
Q2 | $1.11M | Buy |
9,732
+1,081
| +12% | +$123K | 0.91% | 36 |
|
|
2021
Q1 | $936K | Buy |
8,651
+300
| +4% | +$32.5K | 0.83% | 40 |
|
|
2020
Q4 | $895K | Buy |
8,351
+3,001
| +56% | +$322K | 0.83% | 40 |
|
|
2020
Q3 | $469K | Buy |
5,350
+235
| +5% | +$20.6K | 0.49% | 49 |
|
|
2020
Q2 | $502K | Sell |
5,115
-6,410
| -56% | -$629K | 0.59% | 49 |
|
|
2020
Q1 | $878K | Buy |
11,525
+3,725
| +48% | +$284K | 0.86% | 38 |
|
|
2019
Q4 | $691K | Buy |
+7,800
| New | +$691K | 0.52% | 64 |
|
|
2014
Q1 | – | Sell |
-3,850
| Closed | -$203K | – | 115 |
|
|
2013
Q4 | $203K | Buy |
+3,850
| New | +$203K | 0.19% | 113 |
|